BioSante

BioSante Rising as Female Libido Drug Moves Foward
Minyanville
Tue, 10/11/11 - 05:13 pm
female sexual dysfunction
BioSante
LibiGel
Using Options In Speculative Biotech Investing
Seeking Alpha
Mon, 10/10/11 - 11:26 am
Antares Pharma
Aeterna Zentaris
options
Dendreon
BioSante
Keryx
Oncothyreon
Dapagliflozin And Libigel Lead 4 October Healthcare Catalysts
Seeking Alpha
Tue, 10/4/11 - 11:23 am
LibiGel
Dapagliflozin
Antares
AstraZeneca
BioSante
Bristol-Myers Squibb
Teva Pharmaceuticals
Pacira
BioSante: Study Generates Confidence For Future Treatment
Seeking Alpha
Wed, 09/14/11 - 11:46 am
BioSante
LibiGel
female sexual dysfunction
7 Cheap Biotechs That Could Double Or Triple By Next Year
Seeking Alpha
Mon, 09/12/11 - 01:29 pm
Inhibitex
Optimer
Catalyst
Rexahn
Keryx
BioSante
Aeterna Zentaris
A Myriad of Biotech Catalysts Possible at Rodman & Renshaw 2011
CP Wire
Mon, 09/12/11 - 10:34 am
Curis
Rodman & Renshaw
BioSante
Cardium
CytoSorbents
NeurogesX
Supergen
Repros Therapeutics
12 Biotech Stocks the Insiders Are Buying
Motley Fool
Sat, 08/20/11 - 10:09 pm
Ligand
Halozyme
Ziopharm
OPKO Health
Theravance
Celgene
Human Genome Sciences
BioSante
Keryx
GTx
SIGA technologies
SciClone Pharmaceuticals
Antares Pharma: A Promising Pharmaceutical Play
Seeking Alpha
Fri, 08/19/11 - 11:17 am
Antares
BioSante
LibiGel
5 Cheap Biotech Stocks That May Rebound Ahead of the Market
Seeking Alpha
Fri, 08/12/11 - 12:43 pm
BioSante
Chelsea Therapeutics
Dendreon
Keryx
Opexa
Biotech Calendar: 2011-12 FDA Drug Approvals
TheStreet.com
Thu, 08/11/11 - 12:37 pm
biotech
drug approvals
FDA
Eyelea
Regeneron
Dendreon
Provenge
NuPathe
Zelrix
Adcetris
Seattle Genetics
Soliris
Alexion
Dapagliflozin
AstraZeneca
Bristol-Myers Squibb
EXPAREL
Pacira
Roche
Zelboraf
Iluvien
Alimera
Bio-T-Gel
Teva Pharmaceuticals
BioSante
Zevalin
Spectrum
ruxolitinib
Incyte
Novartis
Pfizer
crizotinib
Antares
Anturol
Bydureon
Amlyin
Eli Lilly
Alkermes
AZ-004
Alexza
Corlux
Corcept Therapeutics
Affymax
Takeda
peginesatide
Levadex
MAP Pharmaceuticals
That's All the Melanoma Market Is Worth?
Motley Fool
Sat, 07/23/11 - 03:21 pm
melanoma
BioSante
melanoma vaccine
vaccines
cancer vaccines
BioSante: A Serendipitous Moment?
Seeking Alpha
Fri, 07/22/11 - 11:17 am
BioSante
The 15 Most-Watched BioPharma Stocks
Motley Fool
Wed, 07/13/11 - 04:53 pm
MannKind
Celgene
Amarin
Vertex Pharmaceuticals
BioSante
Keryx
Amylin
Regeneron
Immunogen
Cubist Pharmaceuticals
Isis Pharmaceuticals
Sunesis
OPKO Health
SciClone
Cephalon
BioSante’s Drug for Women’s Sex Drive Spurs Deal-Making Talks, CEO Says
Bloomberg
Mon, 07/11/11 - 06:04 pm
BioSante
female sexual dysfunction
Stephen Simes
LibiGel
10 Biotech Trades for Second Half of 2011
TheStreet.com
Wed, 07/6/11 - 08:51 am
Sangamo BioSciences
BioSante
Seattle Genetics
YM BioSciences
Exelixis
Transcept
Oncothyreon
Gilead Sciences
Medivation
Neoprobe
3 Small Cap Biotech Companies With Future Potential
Seeking Alpha
Fri, 06/24/11 - 10:25 am
Antares
Adventrx
BioSante
With Cancer Vaccines in Play, Will Investors Continue to Buy-In?
Seeking Alpha
Wed, 06/8/11 - 06:50 pm
cancer
vaccines
investors
BioSante
Northwest Biotherapeutics
ImmunoCellular
BioSante Says FDA Lifts Clinical Hold On GVAX Prostate Cancer Vaccine; Shares Up
RTT News
Mon, 06/6/11 - 11:17 am
BioSante
FDA
vaccines
prostate cancer
GVAX
7 Dirt-Cheap Takeover Targets in Biotech
Seeking Alpha
Fri, 06/3/11 - 10:44 am
M&A
Acorda Therapeutics
Antares
Alnylam
BioSante
Catalyst
Inhibitex
Keryx
6 Prime Biotechs for Short- and Long-Term Gains
Seeking Alpha
Tue, 05/31/11 - 05:59 pm
BioSante
Supergen
Acadia
Rexahn
Aeterna Zentaris
Antares

Pages